IL109059A - Pharmaceutical preparations for the treatment of nausea and vomiting after surgery containing granistron - Google Patents

Pharmaceutical preparations for the treatment of nausea and vomiting after surgery containing granistron

Info

Publication number
IL109059A
IL109059A IL10905994A IL10905994A IL109059A IL 109059 A IL109059 A IL 109059A IL 10905994 A IL10905994 A IL 10905994A IL 10905994 A IL10905994 A IL 10905994A IL 109059 A IL109059 A IL 109059A
Authority
IL
Israel
Prior art keywords
placebo
vomiting
granisetron
nausea
treatment
Prior art date
Application number
IL10905994A
Other languages
English (en)
Hebrew (he)
Other versions
IL109059A0 (en
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10732290&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL109059(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of IL109059A0 publication Critical patent/IL109059A0/xx
Publication of IL109059A publication Critical patent/IL109059A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Treatment Of Sludge (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL10905994A 1993-03-18 1994-03-21 Pharmaceutical preparations for the treatment of nausea and vomiting after surgery containing granistron IL109059A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939305593A GB9305593D0 (en) 1993-03-18 1993-03-18 Pharmaceuticals

Publications (2)

Publication Number Publication Date
IL109059A0 IL109059A0 (en) 1994-11-28
IL109059A true IL109059A (en) 1996-11-14

Family

ID=10732290

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10905994A IL109059A (en) 1993-03-18 1994-03-21 Pharmaceutical preparations for the treatment of nausea and vomiting after surgery containing granistron

Country Status (21)

Country Link
US (1) US5952340A (hu)
EP (1) EP0689437B1 (hu)
JP (2) JP3792251B2 (hu)
KR (1) KR100315606B1 (hu)
CN (1) CN1085079C (hu)
AP (1) AP511A (hu)
AT (1) ATE230596T1 (hu)
AU (1) AU676032B2 (hu)
CA (1) CA2158354C (hu)
CY (1) CY2427B1 (hu)
DE (1) DE69431986T2 (hu)
DK (1) DK0689437T3 (hu)
ES (1) ES2188611T3 (hu)
GB (1) GB9305593D0 (hu)
HK (1) HK1012237A1 (hu)
HU (1) HU214629B (hu)
IL (1) IL109059A (hu)
SG (1) SG46724A1 (hu)
TW (1) TW312622B (hu)
WO (1) WO1994021257A1 (hu)
ZA (1) ZA941844B (hu)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9412995D0 (en) * 1994-06-28 1994-10-26 Prendergast Kenneth F Safety enhancing pharmaceutical compositions of an active indazole
WO2003100091A1 (en) * 2002-05-24 2003-12-04 Epidauros Biotechnologie Ag Means and methods for improved treatment using 'setrones'
SE0203410D0 (sv) * 2002-11-18 2002-11-18 Astrazeneca Ab New use
JO2735B1 (en) * 2003-01-30 2013-09-15 هيلسين هيلث كير أس ايه. Liquid pharmaceutical formations of balloonosterone
TWI355936B (en) 2003-02-18 2012-01-11 Helsinn Healthcare Sa Uses of palonosetron hydrochloride
GB0328186D0 (en) * 2003-12-05 2004-01-07 West Pharm Serv Drug Res Ltd Intranasal compositions
JP6081102B2 (ja) * 2012-08-10 2017-02-15 テルモ株式会社 安定なグラニセトロン含有水性製剤
GB201618425D0 (en) * 2016-11-01 2016-12-14 Acacia Pharma Ltd method
JP2017077484A (ja) * 2016-11-30 2017-04-27 テルモ株式会社 安定なグラニセトロン含有水性製剤の包装体
GB201702250D0 (en) 2017-02-10 2017-03-29 Acacia Pharma Ltd Method

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8525913D0 (en) * 1985-10-21 1985-11-27 Beecham Group Plc Compounds
EP0498466B1 (en) * 1985-04-27 2002-07-24 F. Hoffmann-La Roche Ag Indazole-3-carboxamide and -3-carboxylic acid derivatives
GB8928837D0 (en) * 1989-12-21 1990-02-28 Beecham Group Plc Pharmaceuticals
US5225407A (en) * 1990-02-22 1993-07-06 Glaxo Group Limited 5-HT3 receptor antagonists for the treatment of autism
EP0916346A3 (en) * 1991-09-20 2000-12-06 Glaxo Group Limited NK-1 receptor antagonists and 5HT3 receptor antagonists for the treatment of emesis

Also Published As

Publication number Publication date
WO1994021257A1 (en) 1994-09-29
AP9400626A0 (en) 1994-04-30
ES2188611T3 (es) 2003-07-01
AP511A (en) 1996-07-26
AU6377494A (en) 1994-10-11
EP0689437A1 (en) 1996-01-03
CN1085079C (zh) 2002-05-22
CY2427B1 (en) 2004-11-12
DE69431986T2 (de) 2003-11-06
HK1012237A1 (en) 1999-07-30
JPH08507774A (ja) 1996-08-20
ATE230596T1 (de) 2003-01-15
DK0689437T3 (da) 2003-04-28
CA2158354A1 (en) 1994-09-29
IL109059A0 (en) 1994-11-28
EP0689437B1 (en) 2003-01-08
AU676032B2 (en) 1997-02-27
DE69431986D1 (de) 2003-02-13
HU9502692D0 (en) 1995-11-28
SG46724A1 (en) 1998-02-20
US5952340A (en) 1999-09-14
JP3792251B2 (ja) 2006-07-05
KR100315606B1 (ko) 2002-04-24
HUT73502A (en) 1996-08-28
CN1122570A (zh) 1996-05-15
HU214629B (hu) 1998-04-28
ZA941844B (en) 1995-09-18
GB9305593D0 (en) 1993-05-05
CA2158354C (en) 2004-07-13
TW312622B (hu) 1997-08-11
JP2006083190A (ja) 2006-03-30

Similar Documents

Publication Publication Date Title
DE60009697T2 (de) Verwendung von 1-[4-(5-cyanoindol-3yl)butyl]-4-(2-carbamoylbenzofuran-5-yl)piperazin und dessen physiologisch akzeptablen salzen zur behandlung von bipolaren krankheiten und manie
US4804669A (en) Treatment of pain with a piperidine
US5952340A (en) Use of granisetron for the treatment of postoperative nausea and vomiting
NZ504656A (en) Substituted aminomethyl-chromans are used for the regenerative treatment of neurological conditions which are the sequelae of damage due to surgical intervention, exposure to toxic agents, infections, tumours, and other diseases and conditions
US4481206A (en) Spiro succinimide derivative in the treatment of dementia of the Alzheimer type
CA1194799A (en) Method and composition for reducing menstrual pain
JPH0320222A (ja) 脳内虚血症治療剤
US20060160887A1 (en) Medicinal composition
US5876751A (en) Antispasmodic and antinflammatory composition and a process for the manufacture thereof
WO1998038997A1 (en) Use of levobupivacaine in combination with opiods or alfa2-agonists for providing anaesthesia or analgesia
US6162792A (en) Use of spiramycin for treating gastrointestinal disorders caused by H. pylori
GB2189703A (en) Vinpocetine
US9393236B2 (en) Use of 4-cyclopropylmethoxy-N-(3,5-dichloro-1-oxido-4-pyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide in the treatment of cranial traumas
KR20010071893A (ko) 치료 방법
WO2000056336A2 (en) Pharmaceutical compositions comprising a pyrimidine derivative and cyclodextrin
EP0874840A1 (en) Dibenzothiepin derivatives and pharmaceutical compositions
WO1995011027A1 (en) Use of peniclorin for the treatment of posttherapeutic neuralgia
JPH0132804B2 (hu)
MXPA01000466A (en) Method of treatment

Legal Events

Date Code Title Description
CB Opposition filed against grant of patent
HP Change in proprietorship
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired